| Title | Signal Transduction and Targeted Therapy |
| Abbreviation | Signal Transduct. Target. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q1); Genetics (Q1) |
| h-index | 117 |
| Overall Rank/Ranking | 103 |
| SCImago Journal Rank (SJR) | 8.737 |
| Impact Score | 20.66 |
| Publisher | Springer Nature |
| Country | United Kingdom |
| ISSN | 20593635, 20959907 |
| Best Quartile | Q1 |
| Coverage History | 2016-2023 |
Signal Transduction and Targeted Therapy is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Genetics (Q1). It is published by Springer Nature. The overall rank of Signal Transduction and Targeted Therapy is 103. According to SCImago Journal Rank (SJR), this journal is ranked 8.737. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 117. The best quartile for this journal is Q1.
The ISSN of Signal Transduction and Targeted Therapy journal is 20593635, 20959907. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Signal Transduction and Targeted Therapy is cited by a total of 23888 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Signal Transduction and Targeted Therapy is 20.66, which is computed in 2024 as per its definition. Signal Transduction and Targeted Therapy IF is increased by a factor of 1.72 and approximate percentage change is 9.08% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Signal Transduction and Targeted Therapy is 20.66. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 20.66 |
| 2022 | 18.94 |
| 2021 | 17.41 |
| 2020 | 12.91 |
| 2019 | 13.78 |
| 2018 | 6.00 |
| 2017 | 5.52 |
| 2016 | 0.00 |
Signal Transduction and Targeted Therapy has an h-index of 117. It means 117 articles of this journal have more than 117 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Signal Transduction and Targeted Therapy is 20593635, 20959907. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Signal Transduction and Targeted Therapy is 103. According to SCImago Journal Rank (SJR), this journal is ranked 8.737. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 8.737 |
| 2022 | 6.630 |
| 2021 | 5.157 |
| 2020 | 4.284 |
| 2019 | 3.755 |
| 2018 | |
| 2017 | |
| 2016 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 103 |
| 2022 | 156 |
| 2021 | 250 |
| 2020 | 357 |
| 2019 | 437 |
| 2018 | 33911 |
| 2017 | 34677 |
| 2016 | 34114 |
Signal Transduction and Targeted Therapy is published by Springer Nature. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2016-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Signal Transduction and Targeted Therapy is Signal Transduct. Target. Ther.. This abbreviation ('Signal Transduct. Target. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Genetics (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Signal Transduction and Targeted Therapy latest impact IF is 20.66. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 20.66 (2023) and 0.00 (2016), respectively, in the last 8 years. Moreover, its average IS is 11.9 in the previous 8 years.
The Signal Transduction and Targeted Therapy has an SJR (SCImago Journal Rank) of 8.737, according to the latest data. It is computed in the year 2024. In the past 8 years, this journal has recorded a range of SJR, with the highest being 8.737 in 2023 and the lowest being in 2018. Furthermore, the average SJR of the Signal Transduction and Targeted Therapy over the previous 8-year period stands at 11.9.
The latest h-index of the Signal Transduction and Targeted Therapy is 117.
The Signal Transduction and Targeted Therapy is published by the Springer Nature, with its country of publication being the United Kingdom.
The Signal Transduction and Targeted Therapy is currently ranked 103 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this journal has experienced varying rankings, reaching its highest position of 103 in 2023 and its lowest position of 34677 in 2017.
The standard ISO4 abbreviation for the Signal Transduction and Targeted Therapy is Signal Transduct. Target. Ther..
Signal Transduction and Targeted Therapy is classified as a journal that the Springer Nature publishes.
The Signal Transduction and Targeted Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Signal Transduction and Targeted Therapy is assigned the following International Standard Serial Numbers (ISSN): 20593635, 20959907.
The best quartile for the Signal Transduction and Targeted Therapy is Q1 (2023).
The Signal Transduction and Targeted Therapy coverage history can be summarized as follows: 2016-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Journal of Geriatric Physical Therapy | journal | 9578 | Lippincott Williams and Wilkins Ltd. | 47 | 1.23 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Canadian Journal of Education | journal | 18985 | Canadian Society for the Study of Education (CSSE) | 43 | 0.58 |
| Exploration Geophysics | journal | 13768 | Taylor and Francis Ltd. | 50 | 1.06 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 20.66 |
| 2022 | 18.94 |
| 2021 | 17.41 |
| 2020 | 12.91 |
| 2019 | 13.78 |
| 2018 | 6.00 |
| 2017 | 5.52 |
| 2016 | 0.00 |
